Feline diabetes management took a major turn in 2026 when the American Animal Hospital Association published its first dedicated Feline Diabetes Management Guidelines in April, separating cat-specific treatment from the previous approach of applying canine protocols to cats. The new guidelines establish that cats require their own treatment pathways, introduce non-insulin drug options for certain cases, shift how glucose is monitored, and emphasize diet-driven remission in overweight cats. For cat owners, this means your veterinarian may now recommend approaches that were not standard options a year ago—and older guidance that treats cats like "small dogs" with diabetes is no longer current practice.
Table of Contents
- Why Cats Need Different Diabetes Treatment Than Dogs
- Insulin Alternatives for Newly Diagnosed Cats
- Continuous Glucose Monitors Replace Blood Glucose Curves
- Diet and Weight Loss for Remission in Overweight Cats
- Choosing an Approach for Your Cat
Why Cats Need Different Diabetes Treatment Than Dogs
The 2026 guidelines explicitly reject the "cats as small dogs" model for diabetes management, recognizing that cats have distinct biological and metabolic responses to therapy and disease progression. This separation is not cosmetic—it means insulin protocols, drug selection, dietary targets, and monitoring methods are now tailored to how feline biology actually works, not borrowed from canine research.
This shift matters because cats metabolize glucose differently, respond unpredictably to drugs designed for dogs, and can enter remission under conditions that would not work in dogs. If your cat was diagnosed several years ago and your vet has not mentioned the 2026 guidelines, it is worth asking whether management recommendations have been updated.
Insulin Alternatives for Newly Diagnosed Cats
For cats newly diagnosed with diabetes and not yet on insulin, SGLT2-inhibitor drugs are now incorporated into primary management recommendations, following FDA approval of bexagliflozin (marketed as Bexacat, approved 2022) and velagliflozin (Senvelgo, 2023). These drugs work by enabling the kidneys to flush glucose through the urine rather than requiring the pancreas or injected insulin to lower blood sugar.
This matters chiefly for insulin-naive cats—those not yet on daily injections. SGLT2 inhibitors offer an injection-free option that may suit owners who cannot or prefer not to give daily shots, though they are not replacements for insulin in cats already dependent on it. Your veterinarian can discuss whether your cat's specific situation makes an SGLT2 inhibitor a reasonable first step.
Continuous Glucose Monitors Replace Blood Glucose Curves
Monitoring has shifted dramatically. The 2026 guidelines recommend discontinuing routine in-hospital blood glucose curves and instead using continuous glucose monitors (CGMs) for more accurate, non-invasive tracking of glucose trends throughout daily activity. Blood glucose curves—brief snapshots taken in a veterinary clinic—gave incomplete pictures and often stressed already-sick cats.
CGMs are small sensors worn under the skin (or attached like a patch) that transmit glucose readings to a phone or receiver throughout the day and night. They show how your cat's blood sugar responds to meals, activity, and medication over time rather than at isolated moments. If your vet has recommended a CGM but you were skeptical, the 2026 guidelines now back this as the preferred monitoring standard.
Diet and Weight Loss for Remission in Overweight Cats
Low-digestible carbohydrate diets combined with structured caloric restriction substantially improved short-term diabetic remission rates in overweight, insulin-treated cats, according to research presented at the 2026 Western Veterinary Conference. This reinforces an older finding—that diet change can push some cats into remission, meaning normal blood sugar without ongoing medication—but now with clear evidence that weight loss and low-carb nutrition work together.
For overweight cats on insulin, this approach means asking your veterinarian about therapeutic diet options and a weight-management plan. Remission is not guaranteed and requires monitoring, but it is a realistic goal for a subset of cats rather than a rare exception.
Choosing an Approach for Your Cat
The guidelines now offer several paths depending on your cat's age, weight, kidney function, and whether insulin has already been started. A newly diagnosed, normal-weight cat might be a candidate for an SGLT2 inhibitor without insulin.
An overweight cat on insulin could pursue aggressive diet change and weight loss alongside insulin, with remission as a potential outcome. An older cat or one with kidney disease may follow a different protocol. The key is asking your veterinarian how the 2026 guidelines apply to your cat's specific situation—not assuming that previous advice still holds.